NCT00232856View on ClinicalTrials.gov

A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions.

PHASE4CompletedINTERVENTIONAL

Enrollment

162

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

December 31, 2003

Study Completion Date

August 31, 2006

Conditions

Coronary Artery Disease

Interventions

DEVICE

drug-eluting stent

PCI

Trial Locations (2)

3000

K.U. Leuven, Leuven

78189

Herz-zentrum Bad Krozingen, Bad Krozingen

Sponsors

Lead Sponsor

Cordis Corporation

All Listed Sponsors

lead

Cordis Corporation

INDUSTRY